Patel Sanjiv
SEC CIK 1816210 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | Pres, CEO, Dir | 519.5K | — | $15.86M | 33 | 2021-12-31 | 2026-09-08 |
Most active insiders at RLAY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Pauling (Cayman) Ltd | 10% | — | $116.40M |
| 2 | Catinazzo Thomas | CFO | — | $5.18M |
| 3 | Patel Sanjiv | Pres, CEO, Dir | — | $3.61M |
| 4 | Bergstrom Donald A | Pres, R, D | — | $2.36M |
| 5 | Rahmer Peter | See remarks | — | $1.47M |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-09 16:12 | 2026-09-08 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $18.94 | -48.2K | 519.5K | -8% | -$912.9K |
| T | 2026-08-18 16:17 | 2026-08-17 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $20.33 | -48.2K | 567.7K | -8% | -$979.9K |
| T | 2026-07-08 17:08 | 2026-06-30 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $6.95 | +3,056 | 664.1K | +0.5% | +$21.2K |
| T | 2026-07-08 17:08 | 2026-07-07 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $19.58 | -48.2K | 615.9K | -7% | -$943.7K |
| 2026-01-07 | 2026-01-06 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $7.82 | -43.2K | 661.0K | -6% | -$337.6K | |
| 2026-01-07 | 2025-12-31 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $2.99 | +994 | 704.2K | +0.1% | +$2,972 | |
| 2025-11-04 | 2025-11-03 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $7.00 | -62.1K | 703.2K | -8% | -$434.5K | |
| M | 2025-07-10 | 2025-07-09 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $3.57 | -61.4K | 783.9K | -7% | -$219.1K |
| 2025-07-01 | 2025-06-30 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $2.94 | +5,000 | 826.7K | +0.6% | +$14.7K | |
| M | 2025-04-24 | 2025-04-23 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $2.97 | -61.4K | 840.3K | -7% | -$182.4K |
| 2025-02-13 | 2025-02-11 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $0.00 | +332.5K | 958.4K | +53% | $0 | |
| M | 2025-02-13 | 2025-02-11+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $3.80 | -215.5K | 883.1K | -20% | -$818.4K |
| MTI | 2025-01-23 | 2025-01-21+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $4.70 | -375.0K | 199.5K | -65% | -$1.76M |
| TI | 2024-12-18 | 2024-12-16 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $5.00 | -100.0K | 574.5K | -15% | -$500.0K |
| DMT | 2024-07-29 | 2024-07-25+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $5.04 | +86.7K | 802.8K | +12% | +$437.0K |
| DMT | 2024-07-29 | 2024-07-25+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $9.12 | -86.7K | 766.1K | -10% | -$790.9K |
| 2024-07-01 | 2024-06-30 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $5.54 | +2,108 | 766.1K | +0.3% | +$11.7K | |
| 2024-01-18 | 2024-01-16 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $0.00 | +762.4K | 764.0K | +45,870% | $0 | |
| 2023-09-29 | 2023-06-30 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $10.68 | +1,662 | 1,662 | New | +$17.8K | |
| DM | 2023-02-09 | 2023-02-07+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $20.99 | -42.0K | 0 | -100% | -$881.7K |
| DM | 2023-02-09 | 2023-02-07+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $5.04 | +42.0K | 14.0K | New | +$211.7K |
| DM | 2023-01-19 | 2023-01-17+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $5.04 | +84.0K | 282.6K | +42% | +$423.4K |
| DM | 2023-01-19 | 2023-01-17+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $20.37 | -84.0K | 254.6K | -25% | -$1.71M |
| DM | 2022-11-10 | 2022-11-08+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $20.06 | -42.0K | 254.6K | -14% | -$842.5K |
| DM | 2022-11-10 | 2022-11-08+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $4.34 | +42.0K | 272.7K | +18% | +$182.1K |
| DM | 2022-10-13 | 2022-10-11+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $4.12 | +42.0K | 268.6K | +19% | +$173.0K |
| DM | 2022-10-13 | 2022-10-11+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $21.04 | -42.0K | 254.6K | -14% | -$883.7K |
| DM | 2022-09-15 | 2022-09-13+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $4.12 | +42.0K | 268.6K | +19% | +$173.0K |
| DM | 2022-09-15 | 2022-09-13+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $24.24 | -42.0K | 254.6K | -14% | -$1.02M |
| 2022-07-08 | 2022-06-30 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $14.24 | +814 | 254.6K | +0.3% | +$11.6K | |
| DM | 2022-04-14 | 2022-04-12+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $31.42 | -84.0K | 253.7K | -25% | -$2.64M |
| DM | 2022-04-14 | 2022-04-12+ | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $4.43 | +84.0K | 281.7K | +42% | +$371.8K |
| 2022-01-07 | 2021-12-31 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $26.10 | +658 | 253.7K | +0.3% | +$17.2K |
Purchase Sale Sale after option exercise All abbreviations